MX2012008702A - Metodos para controlar internamente o tratar larvas de rezno equinas. - Google Patents

Metodos para controlar internamente o tratar larvas de rezno equinas.

Info

Publication number
MX2012008702A
MX2012008702A MX2012008702A MX2012008702A MX2012008702A MX 2012008702 A MX2012008702 A MX 2012008702A MX 2012008702 A MX2012008702 A MX 2012008702A MX 2012008702 A MX2012008702 A MX 2012008702A MX 2012008702 A MX2012008702 A MX 2012008702A
Authority
MX
Mexico
Prior art keywords
methods
internally controlling
bot larvae
treating equine
larvae
Prior art date
Application number
MX2012008702A
Other languages
English (en)
Inventor
Daniel Earl Snyder
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2012008702A publication Critical patent/MX2012008702A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención se refiere a nuevos métodos y formulaciones para controlar oralmente larvas de rezno en el tracto gastrointestinal del animal equino.
MX2012008702A 2010-01-25 2011-01-20 Metodos para controlar internamente o tratar larvas de rezno equinas. MX2012008702A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29792810P 2010-01-25 2010-01-25
PCT/US2011/021837 WO2011091122A1 (en) 2010-01-25 2011-01-20 Methods for internally controlling or treating equine bot larvae

Publications (1)

Publication Number Publication Date
MX2012008702A true MX2012008702A (es) 2012-08-17

Family

ID=43602871

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008702A MX2012008702A (es) 2010-01-25 2011-01-20 Metodos para controlar internamente o tratar larvas de rezno equinas.

Country Status (13)

Country Link
US (1) US9913824B2 (es)
EP (1) EP2528587B1 (es)
JP (1) JP2013518045A (es)
KR (2) KR20150080647A (es)
CN (1) CN102711730B (es)
AU (1) AU2011207198B2 (es)
BR (1) BR112012018286A2 (es)
CA (1) CA2787078C (es)
EA (1) EA023564B1 (es)
HK (1) HK1172250A1 (es)
MX (1) MX2012008702A (es)
NZ (1) NZ601290A (es)
WO (1) WO2011091122A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2997499A1 (en) 2015-09-03 2017-03-09 Agrimetis, Llc Spinosyn derivatives as insecticides
KR20190103341A (ko) 2017-01-13 2019-09-04 에그리메티스, 엘엘씨 아지리딘 스피노신 유도체 및 제조 방법
US11318155B2 (en) * 2017-02-24 2022-05-03 University Of South Florida Hsp90 activator Aha1 drives production of pathological tau aggregates

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE5591A1 (es) * 1988-12-19 1991-02-15 Lilly Co Eli Un nuevo grupo de compuestos de macrolida
US5362634A (en) 1989-10-30 1994-11-08 Dowelanco Process for producing A83543 compounds
US5202242A (en) 1991-11-08 1993-04-13 Dowelanco A83543 compounds and processes for production thereof
US5591606A (en) 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
US5496932A (en) 1993-04-14 1996-03-05 Henkel Corporation Process for the production of alkylpolyglycoside
US6001981A (en) * 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
BR0013116B1 (pt) * 1999-08-12 2013-01-22 formulaÇÕes orais de dose énica para controlar infestaÇço por ectoparasita em animais de estimaÇço, e seu uso.
DK1373290T3 (da) 2001-03-21 2014-12-01 Dow Agrosciences Llc Pesticidale spinosynderivater
ES2365993T5 (es) * 2001-09-17 2020-06-25 Elanco Us Inc Formulaciones pesticidas
EP1744763B1 (en) * 2004-04-29 2010-01-06 Eli Lilly And Company Spinosyns for wound healing
GB0507490D0 (en) 2005-04-14 2005-05-18 Aq & Plc Treatment of animal parasites
BRPI0718128B8 (pt) 2006-11-03 2022-06-28 Dow Agrosciences Llc Redução seletiva de fatores espinosina et-j e et-l a espinetorama
NZ578259A (en) 2007-02-09 2011-12-22 Pfizer Ltd Antiparasitic agents
MX2011002658A (es) 2008-09-12 2011-04-07 Dow Agrosciences Llc Composiciones plaguicidas.
TW201041510A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity

Also Published As

Publication number Publication date
US9913824B2 (en) 2018-03-13
HK1172250A1 (en) 2013-04-19
KR20120098930A (ko) 2012-09-05
US20120252746A1 (en) 2012-10-04
CA2787078A1 (en) 2011-07-28
BR112012018286A2 (pt) 2018-06-05
CN102711730A (zh) 2012-10-03
AU2011207198A1 (en) 2012-08-30
AU2011207198B2 (en) 2014-10-02
EP2528587B1 (en) 2015-03-18
EA023564B1 (ru) 2016-06-30
EP2528587A1 (en) 2012-12-05
JP2013518045A (ja) 2013-05-20
WO2011091122A1 (en) 2011-07-28
CA2787078C (en) 2015-11-24
EA201290699A1 (ru) 2012-12-28
CN102711730B (zh) 2015-06-17
NZ601290A (en) 2014-04-30
KR20150080647A (ko) 2015-07-09

Similar Documents

Publication Publication Date Title
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
HRP20130357T1 (en) Novel compounds useful for the treatment of degenerative and inflammatory diseases.
SG10201408166QA (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion
DK2611906T3 (da) Systemiske, allogene stamcelleterapier til behandling af sygdomme hos katte og hunde
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
MX2020010607A (es) Compuestos y metodos para inhibir el transporte de fosfato.
IL213070A0 (en) Methods for the treatment of infections and tumors
WO2012048099A3 (en) Nanoparticle-loaded cells
EP2486061A4 (en) COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTICS
DK2410981T4 (da) Tørpulverformuleringer og fremgangsmåder til behandling af lungesygdomme
ZA201202596B (en) Compounds for the treatment of dyslipidemia and related diseases
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
ZA201300426B (en) Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease
PL2575971T3 (pl) Połączone wyciągi roślinne do zastosowania w leczeniu zakażeń drobnoustrojami
EP2249823A4 (en) OCTANOIC ACID FORMULATION AND METHODS OF TREATMENT EMPLOYING THE SAME
SI2874600T1 (sl) Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu
MX2012008702A (es) Metodos para controlar internamente o tratar larvas de rezno equinas.
PL2384623T3 (pl) Kompozycja proszkowa do profilaktyki i leczenia chorób zwierzęcych kopyt
FI20105970A0 (fi) Parannettu ravintokorvaus syövän hoitamiseksi ja ehkäisemiseksi
IL226939A (en) Diarylpyridazinone derivatives, their preparation, and their use in the treatment of humans
IL222642A0 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
UA51074U (ru) Применение экстракта пажитника как средства для лечения экспериментальной язвы желудка и двенадцатиперстной кишки у животных
HU0800011D0 (en) Device for animal transport and for temporary restriction of mokement above all for the sake of therapy
AU2013904443A0 (en) Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (gord/gerd)
GB0613547D0 (en) Treatment of equine laminitis

Legal Events

Date Code Title Description
FG Grant or registration